Peter Kleinhenz

CID Capital Ventures (CID Capital Ventures) is a venture capital subsidiary of CID Capital Inc founded in 1981. CID Capital Ventures is Headquartered in Indianapolis, Indiana.

AxioMed Spine Corp. was formed in 2001 to develop products with a goal of restoring spinal function to patients with degenerative spine disease; thus advancing the standard of care beyond fusion and first generation artificial discs. Since its inception, AxioMed has secured over $34M in private equity financing from prestigious venture capitalists. The company´s Freedom Lumbar Disc has been developed and clinical trials initiated. The company is headed by CEO, Patrick McBrayer, who joined AxioMed in early 2006. Mr. McBrayer along with founder and COO, James Kuras, lead an experienced management and development team with significant history and expertise in spinal implants, including early artificial disc development efforts. Company employment includes professionals with extensive spine and engineering experience. The team is augmented by a Medical Advisory Panel of surgeons from leading spine centers and universities. The company´s headquarters include product development and testing, clinical and regulatory affairs, and manufacturing. AxioMed will leverage its background in lumbar disc replacement with an ongoing development project for the cervical spine.

Redpath Partners, Inc. provides complex cancer diagnostic testing for pathologists, oncologists and clinicians. The company was founded by Del Mary Brady and Sydney D. Finkelstein and is headquartered in Pittsburgh, PA.

Fletcher Spaght Venture Partners LLC (Fletcher Spaght Ventures) is a venture capital subsidiary of Fletcher Spaght Inc founded in 2000 by R John Fletcher Fletcher. The firm is headquartered in Boston, Massachusetts.

Battelle Memorial Institute operates as a science and technology development company. It offers services for government and commercial. The company was founded by Gordon Battelle in 1929 and is headquartered in Columbus, OH.

Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY.

Swift Biosciences, Inc. develops molecular biology reagents. It offers Next Generation Sequencing sample preparation for Illumina and Ion Torrent platforms. The firm?s products include Accel-NGS and Amplicon Panels and myT Primer. The company was founded by David C. Olson and Vladimir L. Makarov in February 2010 and is headquartered in Ann Arbor, MI.

Cayenne Medical, Inc. operates as a sports medicine device company which specializes in the soft tissue reconstruction segments. It focuses on the transformation of traditional arthroscopic procedures, by applying advanced technology through minimally invasive techniques. The firm also provides Quattro systems which are knotless and pre-loaded suture anchors and tailored instrumentations. The company was founded by Ed L. Chang, James W. Hart and Heber C. Crockett in March 2005 and is headquartered in Scottsdale, AZ.